My Profile
Matthew Goldstein
Raising intellectual capital on Wall Street
See all posts
Thu 26 Nov 2009 | 20:17 EST
You are here:
Home
>
Business & Finance
>
Stocks
> Officers and Directors
Home
Business & Finance
Markets
Deals
Small Business
Green Business
Industries
Industry Summits
Stocks
Advanced Stock Search
Overview
Option Quote
Chart
Officers and Directors
Key Developments
Company News
Press Releases
Financial Highlights
Ratios
Financial Statements
Performance
Insider Trading
Institutional Holders
Estimates
Recommendations
Analyst Research
Funds
ETFs
Currencies
Commodities
Options
Economy
Bonds
Analyst Research
Portfolio
News
Do More With Reuters
RSS
Widgets
Mobile
Podcasts
Newsletters
Your View
Make Reuters My Homepage
Partner Services
CareerBuilder
Affiliate Network
Professional Products
Support (Customer Zone)
Reuters Media
Financial Products
About Thomson Reuters
Officers and Directors For Albany Molecular Research, Inc.
Albany Molecular Research, Inc. (AMRI.O) (Nasdaq)
sector:
Healthcare
.
industry:
Pharmaceuticals - Generic & Specialty
ยท
View
AMRI
on other exchanges
As of 25 Nov 2009
8.58
USD
Price Change
+0.06
Percent Change
+0.70%
Analyst Recommendations
Research Another Stock:
Symbol Look-up
Independent Research
|
Broker Research
Summary
Biographies
Basic Compensation
Options Compensation
Name
Age
Since
Current Position
Hagen, Steven
48
2008
Vice President - Pharmaceutical Development and Manufacturing
Jennings, W. Steven
57
2007
Senior Vice President - Sales, Marketing and Business Development
Tartaglia, Anthony
76
2005
Lead Independent Director
O' Connor, Kevin
54
2000
Director
Anderson, Paul
70
2002
Director
Roth, Arthur
69
2003
Director
Jordan, Veronica
58
2006
Director
Ryan, Una
67
2006
Director
Frost, Mark
45
2009
Chief Financial Officer, Senior Vice President - Administration, Treasurer
D' Ambra, Thomas
53
2003
Chairman of the Board, President, Chief Executive Officer
Find out more about AMRI.O
Insider Trading